indole-3-carbinol has been researched along with Lipidoses in 1 studies
indole-3-carbinol: occurs in edible cruciferous vegetables
indole-3-methanol : An indolyl alcohol carrying a hydroxymethyl group at position 3. It is a constituent of the cruciferous vegetables and had anticancer activity.
Lipidoses: Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The histopathologic changes of intestinal lymphangiectasis and lipidosis in this study share similarities with intestinal lymphangiectasia as observed in humans and dogs." | 5.38 | Intestinal lymphangiectasis and lipidosis in rats following subchronic exposure to indole-3-carbinol via oral gavage. ( Boyle, MC; Crabbs, TA; Hill, GD; Lieuallen, WG; Malarkey, DE; Nyska, A; Painter, JT; Wyde, ME, 2012) |
| "The histopathologic changes of intestinal lymphangiectasis and lipidosis in this study share similarities with intestinal lymphangiectasia as observed in humans and dogs." | 1.38 | Intestinal lymphangiectasis and lipidosis in rats following subchronic exposure to indole-3-carbinol via oral gavage. ( Boyle, MC; Crabbs, TA; Hill, GD; Lieuallen, WG; Malarkey, DE; Nyska, A; Painter, JT; Wyde, ME, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyle, MC | 1 |
| Crabbs, TA | 1 |
| Wyde, ME | 1 |
| Painter, JT | 1 |
| Hill, GD | 1 |
| Malarkey, DE | 1 |
| Lieuallen, WG | 1 |
| Nyska, A | 1 |
1 other study available for indole-3-carbinol and Lipidoses
| Article | Year |
|---|---|
Intestinal lymphangiectasis and lipidosis in rats following subchronic exposure to indole-3-carbinol via oral gavage.
Topics: Administration, Oral; Animals; Body Weight; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Female | 2012 |